SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-042442
Filing Date
2021-03-26
Accepted
2021-03-26 16:10:08
Documents
9
Period of Report
2021-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110800d1_8k.htm 8-K 46016
2 EXHIBIT 3.1 tm2110800d1_ex3-1.htm EX-3.1 11727
3 EXHIBIT 3.2 tm2110800d1_ex3-2.htm EX-3.2 174911
4 EXHIBIT 5.1 tm2110800d1_ex5-1.htm EX-5.1 10431
5 EXHIBIT 10.2 tm2110800d1_ex10-1.htm EX-10.1 275140
6 GRAPHIC tm2110800d1_ex3-1img01.jpg GRAPHIC 20258
7 GRAPHIC tm2110800d1_ex3-1img02.jpg GRAPHIC 15800
8 GRAPHIC image_001.jpg GRAPHIC 2964
9 GRAPHIC image_002.jpg GRAPHIC 2964
  Complete submission text file 0001104659-21-042442.txt   578200
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 21777424
SIC: 2836 Biological Products, (No Diagnostic Substances)